Citations
h-index
Documents
Featured Publications
Angew. Chem. Int. Ed.
Angewandte Chemie International Edition · 2026 · e7319820
ACS Catal.
ACS Catalysis · 2025 · 15, 17558
Adv. Funct. Mater.
Advanced Functional Materials · 2025 · 36, e12647
Citations
h-index
Documents
Citations
h-index
Documents
Tribhuvan University | Nepal
Citations
Documents
h-index
CSIR-Indian Institute of Chemical Technology (IICT) | India
Dr. Kiranmai Nayani is an accomplished synthetic organic chemist with extensive research experience in peptide chemistry, asymmetric catalysis, natural product synthesis, and process development for pharmaceutically relevant molecules. She earned her Ph.D. in Synthetic Organic Chemistry from CSIR–IICT, Hyderabad (2005–2010) under the supervision of Dr. Srivari Chandrasekhar, receiving the prestigious Eli Lilly Asia Outstanding Thesis Award (2010). She holds an M.Sc. in Organic Chemistry with Gold Medal from NIT Warangal, a B.Ed. (Institute Topper), and a B.Sc. with Distinction. Dr. Kiranmai currently serves as Senior Scientist at CSIR-IICT, following earlier roles including Project Scientist-III, WOS-A Principal Investigator (DST), Senior Research Associate (CSIR Pool Scientist), Postdoctoral Fellow at Université Paris Descartes (France), and industry positions at Chemveda Life Sciences, Sai Advantium Pharma, and Dr. Reddy’s Laboratories. Her research contributions span organic synthesis, asymmetric dearomatization, foldamers, peptidomimetics, functional peptides, radical cascade reactions, Piancatelli rearrangements, and late-stage functionalization. She has significantly contributed to the synthesis of antimicrobial peptides, including scalable routes to TLR7/8 agonists used as adjuvants in Covaxin, the antiviral drug Nirmatrelvir, and peptide drugs like Dalargin and Plitidepsin.
200
100
50
0
Zhejiang Normal University | China
Assoc. Prof. Dr. Wang Haiyan is a member of the Communist Party of China, an Associate Professor, and a Master’s Supervisor at Zhejiang Normal University. He was selected to the Clarivate Analytics Top 2% Global Scientists list for 2022–2025. He earned his Ph.D. in Chemistry from Zhejiang University under the supervision of Prof. Yong Wang (National Outstanding Young Scientist). During his doctoral training, he also conducted joint research at the Institute of Metal Research, Chinese Academy of Sciences, guided by Researcher Feng Li (National Outstanding Young Scientist). Dr. Wang’s research lies at the intersection of inorganic nanomaterial synthesis and advanced energy storage and conversion systems, including electrocatalysis, hybrid capacitors, and energy-relevant nanostructures. He has authored more than 70 SCI-indexed publications in leading journals such as Nature Communications, Journal of the American Chemical Society, Advanced Energy Materials, Advanced Functional Materials, Nano Energy, ACS Catalysis, and Applied Catalysis B: Environmental. Among his publications, four have been recognized as ESI Hot Papers and eleven as ESI Highly Cited Papers, reflecting strong global influence. His work currently holds an h-index of 38. Dr. Wang has led nine research projects supported by national and provincial funding bodies, including the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. His research contributions have been acknowledged through multiple honors, including a First Prize in the China Association of Inventions Entrepreneurship Innovation Award. Dr. Wang is also highly active in academic mentorship and innovation education. His students have earned numerous prestigious awards, including the Gold Medal at the China International College Student Innovation Competition and top honors in provincial “Challenge Cup” and “Internet+” competitions. He has been recognized as an Outstanding Innovation and Entrepreneurship Mentor and currently serves as Vice President of Technology for a carbon-neutrality-focused enterprise. Additionally, he serves on multiple editorial and technical committees and reviews for leading international journals.
Profile: Scopus
(2026). In situ manipulation of interfacial water in Ni-Co₃O₄ for efficient neutral nitrate electroreduction to ammonia. Applied Catalysis B: Environmental.
(2025). Reciprocal enhancement of iodine and manganese redox kinetics towards high-performance rechargeable zinc-iodine-manganese hybrid batteries. Journal of Energy Chemistry.
(2025). Enhanced energy storage density and efficiency in A/B-site-engineered silver niobate ceramics. Ceramics International.
Electrocatalysts in zinc-iodine batteries: Theoretical insights and material design..
Recent progress in the inhibition of metal dendrites in sodium/potassium ion batteries..
Anhui University | China
Dr. Weidong Wen is an emerging materials scientist whose research focuses on electrocatalytic nitrate reduction to ammonia, plasma-assisted nanoarray catalyst fabrication, and in-situ electrochemical spectroscopy. His work addresses a globally significant scientific challenge: developing sustainable, energy-efficient pathways for ammonia synthesis while contributing to nitrate pollution mitigation. Dr. Wen has established a strong research track record at an early career stage, with multiple publications in high-impact journals such as Advanced Functional Materials and Angewandte Chemie International Edition, where he has served as both first and contributing author. His studies on metastable copper phases, electrolyte microenvironment modulation, and atomically dispersed active sites have expanded fundamental understanding of catalytic mechanisms and enabled the design of high-performance electrocatalysts for selective ammonia production. Collectively, his publications have garnered strong visibility in the materials and electrochemistry communities, reflecting the relevance and novelty of his contributions. Dr. Wen’s academic training includes rigorous research experience across institutions in China and Germany, where he collaborated with interdisciplinary teams and contributed to joint Ph.D. research efforts in solid-state physics and materials engineering. These collaborations have strengthened his expertise in advanced characterization techniques and provided an international dimension to his scientific development. His work has also resulted in impactful insights with potential societal benefits, including pathways to cleaner fertilizer production, reduction of industrial energy consumption, and environmental remediation through nitrate conversion technologies. Throughout his academic career, Dr. Wen has earned multiple institutional scholarships in recognition of his academic excellence, research productivity, and commitment to scientific advancement. With a growing publication record, strong methodological skills, and a clear focus on addressing environmentally relevant challenges, Dr. Wen is positioned to make sustained and influential contributions to materials science, catalysis, and sustainable chemical engineering. His trajectory reflects a promising future as a researcher capable of driving innovations with both scientific and societal relevance.
Profile: Scopus
Guangxi Normal University | China
Ms. Mei-Shan Li is a dedicated Assistant Researcher at the College of Chemistry and Pharmacy, Guangxi Normal University, China. Her research primarily focuses on organic chemistry, natural product chemistry, and medicinal chemistry, with a particular emphasis on the discovery, structural elucidation, and pharmacological evaluation of bioactive compounds derived from traditional medicinal plants. She has contributed significantly to the exploration of alkaloids, terpenoids, and lignans, elucidating their structural diversity and biological potential in combating cancer, viral infections, and inflammatory diseases. With 18 scientific publications, 121 citations, and an h-index of 7, Ms. Li has established herself as a promising early-career researcher in natural product-based drug discovery. Her works have been published in reputable journals such as Phytomedicine, Fitoterapia, Bioorganic & Medicinal Chemistry, and Chemistry & Biodiversity, where she has often served as a co-first or co-corresponding author, underscoring her leadership and technical expertise. Her studies have provided critical insights into TRPV1 inhibitors, novel anticancer agents, and autophagy-related molecular mechanisms, bridging the gap between traditional herbal medicine and modern pharmacology. Beyond academic publications, Ms. Li has co-invented several national patents in China, covering innovative alkaloid derivatives, sesquiterpenoids, and bioactive extraction methods, which showcase her translational approach from bench research to potential industrial applications. She has participated in multiple National Natural Science Foundation of China (NSFC) and regional research projects, focusing on the pharmacological basis of natural compounds and their therapeutic mechanisms in disease models. Through close collaboration with multidisciplinary teams, Ms. Li’s research contributes to drug discovery, public health improvement, and the scientific validation of traditional Chinese medicines. Her work not only enhances the understanding of medicinal plant chemistry but also promotes the sustainable utilization of natural resources for developing novel therapeutic agents. Ms. Mei-Shan Li continues to advance the frontiers of natural product chemistry with a vision to integrate innovation, sustainability, and societal benefit in her scientific pursuits.
Profile: Scopus
Fan, C.-W., Tang, J., Jiang, J.-C., Zhou, M.-M., Li, M.-S., & Wang, H.-S. (2022). Pentagalloylglucose suppresses the growth and migration of human nasopharyngeal cancer cells via the GSK3β/β-catenin pathway in vitro and in vivo. Phytomedicine, 102, 154192.
Luo, L., Luo, J.-Z., Fan, C.-W., Song, X.-X., Wang, C.-Y., Tang, D.-M., Sun, W.-T., Fan, C.-W., Li, M.-S., & Wang, H.-S. (2024). Alkaloids from Corydalis saxicola and their antiproliferative activity against cancer cells. Fitoterapia, 173, 105791.
Luo, J.-Z., Li, M.-S., Song, X.-X., Fang, Y.-L., Mo, H.-N., Jiang, J.-C., Zhao, H.-Y., & Wang, H.-S. (2022). New alkaloids and their in vitro antitumor activity of Corydalis balansae. Fitoterapia, 162, 105289.
Qin, F., Li, M.-S., Li, J.-J., Wang, Y., Wang, K., Zhou, J.-Y., Liang, D., & Wang, H.-S. (2022). Four new sesquiterpenoids from Zanthoxylum nitidum. Chemistry & Biodiversity, 19(7), e202200176.
Fan, C.-W., Li, M.-S., Song, X.-X., Luo, L., Jiang, J.-C., Luo, J.-Z., & Wang, H.-S. (2023). Discovery of novel 2-oximino-2-indolylacetamide derivatives as potent anticancer agents capable of inducing cell autophagy and ferroptosis. Bioorganic & Medicinal Chemistry, 80, 117176.
University of Waterloo, Canada
NIT Srinagar, India
Kyung Hee University, China